Page last updated: 2024-10-15

phosphoserine and Carcinoma, Intraductal, Noninfiltrating

phosphoserine has been researched along with Carcinoma, Intraductal, Noninfiltrating in 1 studies

Phosphoserine: The phosphoric acid ester of serine.

Carcinoma, Intraductal, Noninfiltrating: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neubauer, H1
Clare, SE1
Wozny, W1
Schwall, GP1
Poznanovic, S1
Stegmann, W1
Vogel, U1
Sotlar, K1
Wallwiener, D1
Kurek, R1
Fehm, T1
Cahill, MA1

Other Studies

1 other study available for phosphoserine and Carcinoma, Intraductal, Noninfiltrating

ArticleYear
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
    Breast cancer research : BCR, 2008, Volume: 10, Issue:5

    Topics: Amino Acid Substitution; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninf

2008